QIAGEN NV
QGENF
QGENF was delisted on the 14th of February, 2005.
201 hedge funds and large institutions have $2.88B invested in QIAGEN NV in 2016 Q1 according to their latest regulatory filings, with 34 funds opening new positions, 63 increasing their positions, 74 reducing their positions, and 22 closing their positions.
55% more first-time investments, than exits
New positions opened: 34 | Existing positions closed: 22
34% more call options, than puts
Call options by funds: $90K | Put options by funds: $67K
5% more funds holding
Funds holding: 191 → 201 (+10)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
15% less repeat investments, than reductions
Existing positions increased: 63 | Existing positions reduced: 74
18% less capital invested
Capital invested by funds: $3.5B → $2.88B (-$621M)
Top Buyers
| 1 |
Harris Associates
Chicago,
Illinois
|
+$40.1M |
| 2 |
MNA
Manning & Napier Advisors
Fairport,
New York
|
+$39.8M |
| 3 |
Fiera Capital (Canada)
Montreal,
Quebec, Canada
|
+$25.5M |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$19.4M |
| 5 |
Balyasny Asset Management
Chicago,
Illinois
|
+$17.7M |
Top Sellers
QGENF Hedge Fund Activity: Q1 2016 in Review
201 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in QIAGEN NV (QGENF) for Q1 2016, worth a combined $2.88B — down 18% from $3.5B a quarter earlier.
Buyers outnumbered sellers: 34 funds opened new QGENF positions and 22 closed out — a net gain of 12 holders — while 63 added to existing stakes and 74 trimmed.
The largest buyer was Harris Associates, adding an estimated $40.1M. The largest seller was First Trust Advisors, cutting an estimated $59.9M.
- 201 institutional investors held QIAGEN NV (QGENF) as of Q1 2016, up from 191 in Q4 2015.
- Funds reported $2.88B of QIAGEN NV stock for Q1 2016, down 18% quarter-over-quarter.
- 34 funds opened new QIAGEN NV positions in Q1 2016 and 22 closed out, a net change of +12 holders.
- The largest QIAGEN NV buyer in Q1 2016 was Harris Associates, an estimated $40.1M added.
- The largest QIAGEN NV seller in Q1 2016 was First Trust Advisors, an estimated $59.9M sold.
Based on aggregated 13F filings for Q1 2016.